首页    期刊浏览 2024年12月11日 星期三
登录注册

文章基本信息

  • 标题:A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
  • 本地全文:下载
  • 作者:Joshua B. Rubin ; Andrew L. Kung ; Robyn S. Klein
  • 期刊名称:Proceedings of the National Academy of Sciences
  • 印刷版ISSN:0027-8424
  • 电子版ISSN:1091-6490
  • 出版年度:2003
  • 卷号:100
  • 期号:23
  • 页码:13513-13518
  • DOI:10.1073/pnas.2235846100
  • 语种:English
  • 出版社:The National Academy of Sciences of the United States of America
  • 摘要:The vast majority of brain tumors in adults exhibit glial characteristics. Brain tumors in children are diverse: Many have neuronal characteristics, whereas others have glial features. Here we show that activation of the Gi protein-coupled receptor CXCR4 is critical for the growth of both malignant neuronal and glial tumors. Systemic administration of CXCR4 antagonist AMD 3100 inhibits growth of intracranial glioblastoma and medulloblastoma xenografts by increasing apoptosis and decreasing the proliferation of tumor cells. This reflects the ability of AMD 3100 to reduce the activation of extracellular signal-regulated kinases 1 and 2 and Akt, all of which are pathways downstream of CXCR4 that promote survival, proliferation, and migration. These studies (i) demonstrate that CXCR4 is critical to the progression of diverse brain malignances and (ii) provide a scientific rationale for clinical evaluation of AMD 3100 in treating both adults and children with malignant brain tumors.
国家哲学社会科学文献中心版权所有